Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

WFFS mutation in Thoroughbreds investigated
Mutation is only present at a very low frequency

Mutation is not genetic risk factor and only present at very low frequency

Researchers at the UC Davis School of Veterinary Medicine have published the results of a study that investigated the frequency of the warmblood fragile foal syndrome (WFFS) mutation in Thoroughbreds.

The study demonstrated that this mutation is not a genetic risk factor for catastrophic breakdown and is only present at a very low frequency in this breed.

Warmblood fragile foal syndrome is inherited in an autosomal recessive fashion, meaning that a horse needs to have two copies of the mutation to be affected. WFFS is a fatal genetic defect of connective tissue characterised by hyper-extensible, abnormally thin, fragile skin and mucous membranes.

More than 700 Thoroughbreds were tested for the WFFS mutation, including 22 catastrophic breakdown fatalities. The allele frequency among all samples was 1.2 per cent and the carrier rate (or horses with one copy) was 2.4 per cent. None of the horses in the study had two copies of the mutation and only one of the 22 catastrophic breakdown cases carried the WFFS allele.

Since the allele was found to be present in the Thoroughbred population – albeit at a low frequency – genetic testing could eliminate the possibility of breeding two carriers with the potential of producing an affected offspring.

The UC Davis Veterinary Genetics Laboratory offers a WFFS genetic test and recommends testing for all warmblood breeds.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.